Advertisement

Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction

Published:September 06, 2021DOI:https://doi.org/10.1016/j.amjcard.2021.08.021
      Patients with cancer have an increased risk of cardiovascular events including myocardial infarction (MI) and vice versa, and are at high risks of ischemic and bleeding events after MI. However, short- and long-term clinical outcomes in patients with acute MI based on cancer status are not fully understood. This bi-center registry included 903 patients with acute MI undergoing primary percutaneous coronary intervention in a contemporary setting. Patients were divided into active cancer, a history of cancer, and no cancer according to the status of malignancy. Major adverse cardiovascular events (MACE), a composite of all-cause death, recurrent MI, and stroke, and major bleedings were evaluated. Of 903 patients, 49 (5.4%) and 65 (7.2%) had active cancer and a history of cancer, and 87 (9.6%) patients died during the hospitalization. In-hospital MACE was not significantly different among the 3 groups (16.3% vs 10.8% vs 10.9%, p = 0.48), whereas the rate of major bleeding events during the index hospitalization was significantly higher in patients with active cancer than their counterpart (20.4% vs 6.2% vs 5.8%, p = 0.002). After discharge, patients with active cancer had an increased risk of MACE and major bleedings compared with those with a history of cancer and no cancer during the mean follow-up period of 853 days. In conclusions, active cancer rather than a history of cancer and no cancer had significant impact on in-hospital bleeding events, and MACE and major bleedings after discharge in patients with acute MI undergoing primary percutaneous coronary intervention.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • GBD 2017 Causes of Death Collaborators
        Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
        Lancet. 2018; 392: 1736-1788
        • Sturgeon KM
        • Deng L
        • Bluethmann SM
        • Zhou S
        • Trifiletti DM
        • Jiang C
        • Kelly SP
        • Zaorsky NG.
        A population-based study of cardiovascular disease mortality risk in US cancer patients.
        Eur Heart J. 2019; 40: 3889-3897
        • Handy CE
        • Quispe R
        • Pinto X
        • Blaha MJ
        • Blumenthal RS
        • Michos ED
        • Lima JAC
        • Guallar E
        • Ryu S
        • Cho J
        • Kaye JA
        • Comin-Colet J
        • Corbella X
        • Cainzos-Achirica M.
        Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger.
        Circulation. 2018; 138: 727-734
        • Okura Y
        • Ozaki K
        • Tanaka H
        • Takenouchi T
        • Sato N
        • Minamino T.
        The impending epidemic of cardiovascular diseases in patients with cancer in Japan.
        Circ J. 2019; 83: 2191-2202
        • Zamorano JL
        • Lancellotti P
        • Rodriguez Muñoz D
        • Aboyans V
        • Asteggiano R
        • Galderisi M
        • Habib G
        • Lenihan DJ
        • Lip GYH
        • Lyon AR
        • Lopez Fernandez T
        • Mohty D
        • Piepoli MF
        • Tamargo J
        • Torbicki A
        • Suter TM
        • ESC Scientific Document Group
        2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
        Eur Heart J. 2016; 37: 2768-2801
        • Velders MA
        • Boden H
        • Hofma SH
        • Osanto S
        • van der Hoeven BL
        • Heestermans AA
        • Cannegieter SC
        • Jukema JW
        • Umans VA
        • Schalij MJ
        • van Boven AJ.
        Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.
        Am J Cardiol. 2013; 112: 1867-1872
        • Iannaccone M
        • D'Ascenzo F
        • Vadalà P
        • Wilton SB
        • Noussan P
        • Colombo F
        • Raposeiras Roubín S
        • Abu Assi E
        • González-Juanatey JR
        • Simao Henriques JP
        • Saucedo J
        • Kikkert WJ
        • Nuñez-Gil I
        • Ariza-Sole A
        • Song XT
        • Alexopoulos D
        • Liebetrau C
        • Kawaji T
        • Moretti C
        • Garbo R
        • Huczek Z
        • Nie SP
        • Fujii T
        • Correia LC
        • Kawashiri MA
        • García Acuña JM
        • Southern D
        • Alfonso E
        • Terol B
        • Garay A
        • Zhang D
        • Chen Y
        • Xanthopoulou I
        • Osman N
        • Möllmann H
        • Shiomi H
        • Giordana F
        • Kowara M
        • Filipiak K
        • Wang X
        • Yan Y
        • Fan JY
        • Ikari Y
        • Nakahashi T
        • Sakata K
        • Gaita F
        • Yamagishi M
        • Kalpak O
        • Kedev S
        Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy.
        Eur Heart J Acute Cardiovasc Care. 2018; 7: 631-638
        • Bharadwaj A
        • Potts J
        • Mohamed MO
        • Parwani P
        • Swamy P
        • Lopez-Mattei JC
        • Rashid M
        • Kwok CS
        • Fischman DL
        • Vassiliou VS
        • Freeman P
        • Michos ED
        • Mamas MA.
        Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
        Eur Heart J. 2020; 41: 2183-2193
        • Mohamed MO
        • Van Spall HGC
        • Kontopantelis E
        • Alkhouli M
        • Barac A
        • Elgendy IY
        • Khan SU
        • Kwok CS
        • Shoaib A
        • Bhatt DL
        • Mamas MA.
        Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis.
        Eur Heart J Acute Cardiovasc Care. 2021; https://doi.org/10.1093/ehjacc/zuaa032
        • Rohrmann S
        • Witassek F
        • Erne P
        • Rickli H
        • Radovanovic D.
        Treatment of patients with myocardial infarction depends on history of cancer.
        Eur Heart J Acute Cardiovasc Care. 2018; 7: 639-645
        • Hess CN
        • Roe MT
        • Clare RM
        • Chiswell K
        • Kelly J
        • Tcheng JE
        • Hagstrom E
        • James SK
        • Khouri MG
        • Hirsch BR
        • Kong DF
        • Abernethy AP
        • Krucoff MW.
        Relationship between cancer and cardiovascular outcomes following percutaneous coronary intervention.
        J Am Heart Assoc. 2015; 4e001779
        • Iliescu CA
        • Grines CL
        • Herrmann J
        • Yang EH
        • Cilingiroglu M
        • Charitakis K
        • Hakeem A
        • Toutouzas KP
        • Leesar MA
        • Marmagkiolis K.
        SCAI Expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista).
        Catheter Cardiovasc Interv. 2016; 87: E202-E223
        • Thygesen K
        • Alpert JS
        • Jaffe AS
        • Chaitman BR
        • Bax JJ
        • Morrow DA
        • White HD
        • Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction
        Fourth universal definition of myocardial infarction (2018).
        J Am Coll Cardiol. 2018; 72: 2231-2264
        • Ozaki Y
        • Katagiri Y
        • Onuma Y
        • Amano T
        • Muramatsu T
        • Kozuma K
        • Otsuji S
        • Ueno T
        • Shiode N
        • Kawai K
        • Tanaka N
        • Ueda K
        • Akasaka T
        • Hanaoka KI
        • Uemura S
        • Oda H
        • Katahira Y
        • Kadota K
        • Kyo E
        • Sato K
        • Sato T
        • Shite J
        • Nakao K
        • Nishino M
        • Hikichi Y
        • Honye J
        • Matsubara T
        • Mizuno S
        • Muramatsu T
        • Inohara T
        • Kohsaka S
        • Michishita I
        • Yokoi H
        • Serruys PW
        • Ikari Y
        • Nakamura M
        • Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT)
        CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.
        Cardiovasc Interv Ther. 2018; 33: 178-203
        • Saito Y
        • Kobayashi Y
        • Fujii K
        • Sonoda S
        • Tsujita K
        • Hibi K
        • Morino Y
        • Okura H
        • Ikari Y
        • Honye J.
        Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics.
        Cardiovasc Interv Ther. 2020; 35: 1-12
        • Sonoda S
        • Hibi K
        • Okura H
        • Fujii K
        • Honda Y
        • Kobayashi Y.
        Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions.
        Cardiovasc Interv Ther. 2020; 35: 30-36
        • Fujii K
        • Kubo T
        • Otake H
        • Nakazawa G
        • Sonoda S
        • Hibi K
        • Shinke T
        • Kobayashi Y
        • Ikari Y
        • Akasaka T.
        Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography.
        Cardiovasc Interv Ther. 2020; 35: 13-18
        • Saito Y
        • Kobayashi Y.
        Contemporary coronary drug-eluting and coated stents: a mini-review.
        Cardiovasc Interv Ther. 2021; 36: 20-22
        • Garcia-Garcia HM
        • McFadden EP
        • Farb A
        • Mehran R
        • Stone GW
        • Spertus J
        • Onuma Y
        • Morel MA
        • van Es GA
        • Zuckerman B
        • Fearon WF
        • Taggart D
        • Kappetein AP
        • Krucoff MW
        • Vranckx P
        • Windecker S
        • Cutlip D
        • Serruys PW
        • Academic Research Consortium
        Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document.
        Circulation. 2018; 137: 2635-2650
        • Hicks KA
        • Stockbridge NL
        • Targum SL
        • Temple RJ.
        Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective.
        Circulation. 2011; 123: 2664-2665
        • Roule V
        • Verdier L
        • Blanchart K
        • Ardouin P
        • Lemaitre A
        • Bignon M
        • Sabatier R
        • Alexandre J
        • Beygui F.
        Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention.
        BMC Cardiovasc Disord. 2020; 20: 38
        • Nakatsuma K
        • Shiomi H
        • Morimoto T
        • Watanabe H
        • Nakagawa Y
        • Furukawa Y
        • Kadota K
        • Ando K
        • Ono K
        • Shizuta S
        • Kimura T
        • CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators
        Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).
        Eur Heart J Qual Care Clin Outcomes. 2018; 4: 200-207
        • Guo W
        • Fan X
        • Lewis BR
        • Johnson MP
        • Rihal CS
        • Lerman A
        • Herrmann J.
        Cancer patients have a higher risk of thrombotic and ischemic events after percutaneous coronary intervention.
        JACC Cardiovasc Interv. 2021; 14: 1094-1105
        • Kanenawa K
        • Yamaji K
        • Morinaga T
        • Hiromasa T
        • Hayashi M
        • Hiramori S
        • Tomoi Y
        • Kuramitsu S
        • Domei T
        • Hyodo M
        • Soga Y
        • Shirai S
        • Ando K.
        Clinical outcomes after percutaneous coronary intervention in patients with cancer.
        Circ J. 2021; 85: 837-846
        • Urban P
        • Mehran R
        • Colleran R
        • Angiolillo DJ
        • Byrne RA
        • Capodanno D
        • Cuisset T
        • Cutlip D
        • Eerdmans P
        • Eikelboom J
        • Farb A
        • Gibson CM
        • Gregson J
        • Haude M
        • James SK
        • Kim HS
        • Kimura T
        • Konishi A
        • Laschinger J
        • Leon MB
        • Magee PFA
        • Mitsutake Y
        • Mylotte D
        • Pocock S
        • Price MJ
        • Rao SV
        • Spitzer E
        • Stockbridge N
        • Valgimigli M
        • Varenne O
        • Windhoevel U
        • Yeh RW
        • Krucoff MW
        • Morice MC.
        Defining high bleeding risk in patients undergoing percutaneous coronary intervention.
        Circulation. 2019; 140: 240-261
        • Saito Y
        • Kobayashi Y.
        Academic research consortium definition of high bleeding risk in clinical practice- validation and beyond.
        Circ J. 2021; 85: 806-807
        • Nakamura M
        • Kadota K
        • Nakao K
        • Nakagawa Y
        • Shite J
        • Yokoi H
        • Kozuma K
        • Tanabe K
        • Iijima R
        • Harada A
        • Kuroda T
        • Murakami Y.
        High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
        EuroIntervention. 2021; 16: 1154-1162
        • Ueki Y
        • Bär S
        • Losdat S
        • Otsuka T
        • Zanchin C
        • Zanchin T
        • Gragnano F
        • Gargiulo G
        • Siontis GCM
        • Praz F
        • Lanz J
        • Hunziker L
        • Stortecky S
        • Pilgrim T
        • Heg D
        • Valgimigli M
        • Windecker S
        • Räber L.
        Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
        EuroIntervention. 2020; 16: 371-379
        • Corpataux N
        • Spirito A
        • Gragnano F
        • Vaisnora L
        • Galea R
        • Svab S
        • Gargiulo G
        • Zanchin T
        • Zanchin C
        • Siontis GCM
        • Praz F
        • Lanz J
        • Hunziker L
        • Stortecky S
        • Pilgrim T
        • Räber L
        • Capodanno D
        • Urban P
        • Pocock S
        • Heg D
        • Windecker S
        • Valgimigli M.
        Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk.
        Eur Heart J. 2020; 41: 3743-3749
        • Cao D
        • Mehran R
        • Dangas G
        • Baber U
        • Sartori S
        • Chandiramani R
        • Stefanini GG
        • Angiolillo DJ
        • Capodanno D
        • Urban P
        • Morice MC
        • Krucoff M
        • Goel R
        • Roumeliotis A
        • Sweeny J
        • Sharma SK
        • Kini A.
        Validation of the Academic Research Consortium high bleeding risk definition in contemporary PCI patients.
        J Am Coll Cardiol. 2020; 75: 2711-2722